Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Chemotherapy Regimens with Stem Cell Transplant in High-Risk Breast Cancer
NCT00003972Phase 3Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jul 1998
- Primary completion
- Mar 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of busulfan, melphalan, thiotepa, cyclophosphamide, carboplatin in breast cancer, sponsored by Fred Hutchinson Cancer Center. Started Jul 1998; status: completed.
02
Drugs
busulfanmelphalanthiotepacyclophosphamidecarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003972.